Predictive and prognostic biomarkers for immunotherapy in lung cancer

Gynaecological cancer: New targets and immunotherapy developments

Potential benefit to response rates from trastuzumab added to perioperative chemotherapy for patients with HER-2+ GC

Botensilimab plus balstilimab for metastatic heavily pretreated microsatellite stable colorectal cancer

Rationale for routine use of IORT for early breast cancer and data for specific indications

Lisocabtagene maraleucel is efficacious at treating R/R chronic lymphocytic leukaemia/small lymphocytic lymphoma

ASCO 2023: Lung cancer research highlights

Real-world use of brexu-cel shows benefit in R/R mantle cell lymphoma treatment

Venetoclax and ibrutinib therapy shows favourable results in the treatment of R/R chronic lymphocytic leukaemia

Pembrolizumab benefits patients with brain metastases

Selinexor, bortezomib and dexamethasone shows PFS benefit for multiple myeloma

ADCLEC.syn1 and CD33-CARS in humanised acute myeloid leukaemia models shows promising efficacy